Impact of Glomerular filtration rate on clinical outcomes after carotid artery revascularization in 11,832 patients from the CARE registry ®

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 2, 2014, Pages 246-254

  Gruberg, Luis ^a   Jeremias, Allen ^a   Rundback, John H ^b   Anderson, H Vernon ^c   Spertus, John A ^d   Kennedy, Kevin F ^d   Rosenfield, Kenneth A ^e  

^a STONY BROOK UNIVERSITY   (United States)

^b Holy Name Hospital   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cerebrovascular disease; chronic renal insufficiency; peripheral vascular disease

Indexed keywords

CREATININE; BIOLOGICAL MARKER;

AGE; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CAROTID ARTERY REVASCULARIZATION; CAROTID ARTERY STENTING; CAROTID ARTERY SURGERY; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CHRONIC LUNG DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; REVASCULARIZATION; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK; ADVERSE EFFECTS; ANGIOPLASTY; BLOOD; CAROTID ARTERY DISEASES; COMPLICATION; DEVICES; KIDNEY; KIDNEY DISEASE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; REGISTER; STENT; STROKE; TIME; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; COMORBIDITY; CREATININE; ENDARTERECTOMY, CAROTID; FEMALE; GLOMERULAR FILTRATION RATE; HOSPITAL MORTALITY; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84904433924     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25101     Document Type: Article

References (28)

1. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis: North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1991; 325: 445-1953.
2. Randomized trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 1379-1387.
3. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis: European Carotid Surgery Trialists' Collaborative Group. Lancet 1991; 337: 1235-1243.
4. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995; 273: 1421-1428.
5. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, Degraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL,. Primary prevention of ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council: Cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline. Stroke 2006; 37: 1583-1633.
6. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K,. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493-1501.
7. Ringleb PA, Allenberg J, Bruckmann H, et al. 30 Day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial. Lancet 2006; 368: 1239-1247.
8. Mas JL, Chatellier G, Beyssen B, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W,. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1660-1671.
9. Brott TG, Hobson RW II, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF,; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010; 363: 11-23.
10. Gruberg L, Weissman NJ, Waksman R, Laird JR Jr, Pinnow EE, Wu H, Deible R, Kent KM, Pichard AD, Satler LF, Lindsay J Jr,. Comparison of outcomes of percutaneous coronary revascularization with stents in patients with and without mild chronic renal failure. Am J Cardiol 2002; 89: 54-57.
11. Gruberg L, Dangas G, Mehran R, Hong MK, Waksman R, Mintz GS, Kent KM, Pichard AD, Satler LF, Lansky AJ, Stone GW, Leon MB,. Clinical outcome following percutaneous interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 2002; 55: 66-72.
12. Gibson CM, Dumaine RL, Gelfand EV, Murphy SA, Morrow DA, Wiviott SD, Giugliano RP, Cannon CP, Antman EM, Braunwald E,; TIMI Study Group. Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome observations in 13,307 patients in five TIMI trials. Eur Heart J 2004; 25: 1998-2005.
13. Saw J, Gurm HS, Fathi RB, Bhatt DL, Abou-Chebl A, Bajzer C, Yadav JS,. Effect of chronic kidney disease on outcomes after carotid artery stenting. Am J Cardiol 2004; 94: 1093-1096.
14. White CJ, Anderson HV, Brindis RG, Cates CU, Cohen DJ, Ho K, Hopkins LN, Jaff MR, Koroshetz WJ, Rosenfield KA,. The Carotid Artery Revascularization and Endarterectomy (CARE) Registry: Objectives, design, and implications. Catheter Cardiovasc Interv 2008; 71: 721-725.
15. Available at: www.ncdr.com/webncdr/common/.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation; Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
17. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: 1-266.
18. Longmore RB, Yeh RW, Kennedy KF, Anderson HV, White CJ, Longmore LS, Rosenfield K, Ho KK, Spertus JA,. Clinical referral patterns for carotid artery stenting versus carotid endarterectomy: Results from the Carotid Artery Revascularization and Endarterectomy Registry. Circ Cardiovasc Interv 2011; 4: 88-94.
19. Hawkins BM, Kennedy KF, Giri J, Saltzman AJ, Rosenfield K, Drachman DE, White CJ, Spertus JA, Yeh RW,. Pre-procedural risk quantification for carotid stenting using the CAS score: A report from the NCDR CARE registry. J Am Coll Cardiol 2012; 60: 1617-1622.
20. Carotid Stenting Trialists' Collaboration. Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: A preplanned meta-analysis of individual patient data. Lancet 2010; 376: 1062-1073.
21. International Carotid Stenting Study investigators. Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): An interim analysis of a randomised controlled trial. Lancet 2010; 375: 985-997.
22. Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V,. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: Prospective population based cohort study. BMJ 2010; 341: c4986.
23. Hage FG, Venkataraman R, Zoghbi GJ, Perry GJ, DeMattos AM, Iskandrian AE,. The scope of coronary heart disease in patients with chronic kidney disease. J Am Coll Cardiol 2009; 53: 2129-2140.
24. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D,. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219.
25. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
26. Mann JFE, Gerstein HC, Poque J, Bosch J, Yusuf S,. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randomized trial. Ann Intern Med 2001; 134: 629-636.
27. Mann JFE, Gerstein HC, Dulau-Florea I, Lonn E,. Cardiovascular risk in patients with mild renal insufficiency. Kidney Int Suppl 2003; 63 (Suppl. 84): S192-S196.
28. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, Zanchetti A,. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218-225.